• Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

  • 2024/11/19
  • 再生時間: 3 分
  • ポッドキャスト

Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

  • サマリー

  • Author: Strober J, et al.
    Overview Provided by Nicolas Silvestri, MD

    続きを読む 一部表示

あらすじ・解説

Author: Strober J, et al.
Overview Provided by Nicolas Silvestri, MD

Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Studyに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。